Adjunctive glaucoma therapy use associated with travoprost, bimatoprost, and latanoprost

By Covert David   Robin Alan L.  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 971-976

Informa Healthcare

Access to resources Recommend Favorite

Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma

By Holmstrom Stefan   Buchholz Patricia   Walt John   Wickstrøm Jannie   Aagren Mark  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1875-1883

Informa Healthcare

Access to resources Recommend Favorite

An adherence based cost–consequence model comparing bimatoprost 0.01% to bimatoprost 0.03%

By Wong William B.   Patel Vaishali D.   Kowalski Jonathan W.   Schwartz Gail  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1191-1200

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%

By Frenkel Ronald E.   Noecker Robert J.   Craven E. Randy  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 919-923

Informa Healthcare

Access to resources Recommend Favorite

Nutritional Risk in Inner‐City‐Dwelling Older Black Americans

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 8, 1996-08 ,pp. : 959-962

John Wiley & Sons Inc

Access to resources Recommend Favorite